| P2093 | author name string | Bo Zhou | |
| | Jianqing She | |
| | Yulong Xia | |
| P2860 | cites work | Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus | Q29614922 |
| | Liver injury correlates with biomarkers of autoimmunity and disease activity and represents an organ system involvement in patients with systemic lupus erythematosus | Q33424303 |
| | Assessment of systemic lupus erythematosus | Q36307628 |
| | Short-term patient-centered nutrition counseling impacts weight and nutrient intake in patients with systemic lupus erythematosus | Q36509296 |
| | Management of dyslipidemia in children and adolescents with systemic lupus erythematosus | Q36915663 |
| | Update on cardiovascular disease in lupus | Q38844782 |
| | Dyslipidemia in systemic lupus erythematosus | Q39123611 |
| | The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus | Q40974327 |
| | Hydroxychloroquine reduces low-density lipoprotein cholesterol levels in systemic lupus erythematosus: a longitudinal evaluation of the lipid-lowering effect. | Q41929433 |
| | Lymphopenia is a risk factor in the progression of carotid intima-media thickness in juvenile-onset systemic lupus erythematosus | Q43233237 |
| | Lipid profiles in patients with systemic lupus erythematosus | Q43893016 |
| | Effect of a culturally sensitive cholesterol lowering diet program on lipid and lipoproteins, body weight, nutrient intakes, and quality of life in patients with systemic lupus erythematosus | Q44176111 |
| | Serum lipoprotein(a) level and its clinical significance in patients with systemic lupus erythematosus | Q44226563 |
| | Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. | Q44441787 |
| | Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations | Q45217508 |
| | Differential reactive oxygen species production of neutrophils and their oxidative damage in patients with active and inactive systemic lupus erythematosus | Q46422998 |
| | Heart failure in systemic lupus erythematosus | Q50015650 |
| | Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies. | Q51577475 |
| | Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. | Q51631986 |
| | Plasma lipoprotein levels as predictors of cardiovascular death in women. | Q55066023 |
| | Impact of Dietary Cholesterol on the Pathophysiology of Infectious and Autoimmune Disease. | Q55515189 |
| | Shotgun Lipidomics Revealed Altered Profiles of Serum Lipids in Systemic Lupus Erythematosus Closely Associated with Disease Activity | Q57034075 |
| | Athérosclérose au cours du lupus érythémateux systémique | Q58621602 |
| | Chylomicron metabolism is markedly altered in systemic lupus erythematosus | Q61974594 |
| | Morphological detection and quantification of lipoprotein(a) deposition in atheromatous lesions of human aorta and coronary arteries | Q68422376 |
| | Systemic lupus erythematosus disease activity index 2000 | Q77624632 |
| | Atherosclerosis-related markers in systemic lupus erythematosus patients: the role of humoral immunity in enhanced atherogenesis | Q77794855 |
| | Clinical and laboratory aspects of dyslipidemia in Brazilian women with systemic lupus erythematosus | Q87998045 |
| | [Dyslipidaemia and atherogenic risk in patients with systemic lupus erythematosus] | Q89233673 |
| | Urinary Neutrophil Gelatinase-Associated Lipocalin and Urinary Soluble CXCL16 as Biomarkers of Activity in Pediatric Lupus Nephritis | Q91063521 |
| | The Relationships of High-Sensitivity C-Reactive Protein and Homocysteine Levels With Disease Activity, Damage Accrual, and Cardiovascular Risk in Systemic Lupus Erythematosus | Q91433266 |
| | Interleukin-17/Interleukin-21 and Interferon-γ producing T cells specific for β2 Glycoprotein I in atherosclerosis inflammation of systemic lupus erythematosus patients with antiphospholipid syndrome | Q92369603 |
| | Progression of atherosclerosis versus arterial stiffness with age within and between arteries in systemic lupus erythematosus | Q92404006 |
| | Acute Myocardial Infarction Outcomes in Systemic Lupus Erythematosus (from the Nationwide Inpatient Sample) | Q93050243 |
| | Maintenance therapy for lupus nephritis with mycophenolate mofetil or azathioprine. A meta-analysis | Q95395055 |
| P433 | issue | 1 | |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| P304 | page(s) | 40 | |
| P577 | publication date | 2020-03-14 | |
| P1433 | published in | Lipids in Health and Disease | Q15756695 |
| P1476 | title | Dysregulated serum lipid profile and its correlation to disease activity in young female adults diagnosed with systemic lupus erythematosus: a cross-sectional study | |
| P478 | volume | 19 | |